This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Endocyte, Inc.. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2025
Title: Albert E. Felten: Innovator in Pharmaceutical Conjugates
Introduction: Albert E. Felten is a prominent inventor based in Lafayette, IN, known for his contributions to the field of pharmaceuticals. He holds one patent that focuses on innovative treatments for diseases, showcasing his dedication to improving healthcare through scientific advancements.
Latest Patents: Albert's patent, titled "Conjugates for treating diseases," involves pyrrolobenzodiazepine (PBD) prodrugs and their conjugates. This groundbreaking work provides insights into pharmaceutical compositions of the conjugates and outlines methods for their production and usage.
Career Highlights: Albert is affiliated with Endocyte, Inc., where he employs his expertise to develop novel pharmaceutical solutions. His patent clearly indicates his significant role in pioneering therapeutic innovations that aim to enhance treatment efficacy for various medical conditions.
Collaborations: Throughout his career, Albert has collaborated with talented professionals, including Iontcho Radoslavov Vlahov and Christopher Paul Leamon. These partnerships reflect a shared vision for advancing pharmaceutical research and fostering innovation in the industry.
Conclusion: Albert E. Felten's contributions to pharmaceutical science illustrate the impact of innovative thinking in addressing healthcare challenges. His work continues to inspire others in the field, demonstrating the importance of inventors in creating solutions that advance medical science and improve patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile